Bravado Pharmaceuticals

Overview

Bravado Pharmaceuticals is a pharmaceutical development and manufacturing company based in Lutz, Florida, specializing in contract development and manufacturing services. The company focuses on formulation development, analytical testing, and early-phase clinical manufacturing across a broad range of dosage forms.

Core Capabilities

Formulation & Development:

• Complex pharmaceutical dosage forms including multi-layer tablet systems and combination products
• Bioavailability enhancement using complexation and solid-state dispersion technologies
• Development across ophthalmic, oral solid, oral liquid, semi-solid, parenteral, and topical dosage forms
• Analytical method development and testing

Leadership & Expertise: Founded and led by Brian McMillan, M.S., President & CEO, a pharmaceutical development scientist with over 30 years of experience in analytical and formulation development. McMillan has served as lead scientist or key contributor in the development of more than 200 pharmaceutical products and brings extensive expertise from roles at Roxane Laboratories, Bausch & Lomb Pharmaceuticals, MDS Pharma Services, and CoreRx (where he served as Co-Founder and Chief Technology Officer).

Notable Development Experience:

• Retisert® (intravitreal implant for uveitis) — lead formulation and process development scientist
• Peramivir (Rapivab®) — development of solution, suspension, and lyophilized dosage forms; lyophilized formulation stockpiled by U.S. government for H1N1 pandemic preparedness
• Contrave® — lead scientist for formulation platforms (first FDA-approved combination drug for chronic weight management)
• PALFORZIA® — initial formulator for first FDA-approved oral immunotherapy for peanut allergy
• CoVer Nasal Antibody Drops — formulation development of intranasal antibody platform in collaboration with Stanford University and SPARK GLOBAL

Service Model: Bravado designs each development program based on client needs, offering short timelines and high-quality service. The company provides services from R&D through early-phase clinical manufacturing.